Corcept Therapeutics Incorporated (CORT) — Net Asset Quality Index
Corcept Therapeutics Incorporated (CORT) has a Net Asset Quality Index of 78.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $814.88 Million minus total liabilities of $176.89 Million yields net assets of $637.99 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read CORT total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Corcept Therapeutics Incorporated Net Asset Quality Index Over Time (2000–2025)
This chart shows how Corcept Therapeutics Incorporated's Net Asset Quality Index has evolved across 26 annual periods from 2000 to 2025. As of March 2026, the index stands at 78.3%, representing net assets of $637.99 Million against total assets of $814.88 Million USD. For live market cap and overall valuation, see market cap of Corcept Therapeutics Incorporated.
Annual Net Asset Quality Index for Corcept Therapeutics Incorporated (2000–2025)
The table below presents the year-by-year Net Asset Quality Index for Corcept Therapeutics Incorporated from 2000 to 2025, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check CORT strategic asset allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 77.4% | $647.80 Million | $836.65 Million | $188.85 Million | ▼ -3.4 pp |
| 2024 | 80.9% | $679.59 Million | $840.55 Million | $160.96 Million | ▼ -0.7 pp |
| 2023 | 81.5% | $506.70 Million | $621.52 Million | $114.81 Million | ▼ -4.5 pp |
| 2022 | 86.0% | $501.84 Million | $583.43 Million | $81.59 Million | ▼ -2.7 pp |
| 2021 | 88.7% | $375.81 Million | $423.76 Million | $47.95 Million | ▼ -2.9 pp |
| 2020 | 91.5% | $523.34 Million | $571.73 Million | $48.39 Million | ▲ +1.5 pp |
| 2019 | 90.0% | $371.18 Million | $412.31 Million | $41.13 Million | ▲ +1.5 pp |
| 2018 | 88.5% | $275.88 Million | $311.69 Million | $35.81 Million | ▲ +1.9 pp |
| 2017 | 86.6% | $190.97 Million | $220.54 Million | $29.57 Million | ▲ +26.4 pp |
| 2016 | 60.2% | $41.38 Million | $68.75 Million | $27.37 Million | ▲ +24.6 pp |
| 2015 | 35.6% | $18.50 Million | $51.94 Million | $33.44 Million | ▲ +45.4 pp |
| 2014 | -9.8% | $-3.39 Million | $34.63 Million | $38.02 Million | ▼ -43.1 pp |
| 2013 | 33.3% | $21.02 Million | $63.08 Million | $42.06 Million | ▼ -29.0 pp |
| 2012 | 62.3% | $61.78 Million | $99.17 Million | $37.39 Million | ▼ -25.1 pp |
| 2011 | 87.4% | $34.81 Million | $39.83 Million | $5.03 Million | ▲ +2.8 pp |
| 2010 | 84.6% | $21.24 Million | $25.10 Million | $3.86 Million | ▼ -5.5 pp |
| 2009 | 90.1% | $22.09 Million | $24.51 Million | $2.42 Million | ▲ +4.6 pp |
| 2008 | 85.5% | $16.91 Million | $19.77 Million | $2.87 Million | ▲ +2.5 pp |
| 2007 | 83.0% | $14.73 Million | $17.74 Million | $3.01 Million | ▲ +18.8 pp |
| 2006 | 64.2% | $6.36 Million | $9.90 Million | $3.54 Million | ▼ -24.0 pp |
| 2005 | 88.2% | $26.59 Million | $30.16 Million | $3.56 Million | ▼ -8.0 pp |
| 2004 | 96.2% | $45.95 Million | $47.77 Million | $1.82 Million | ▲ +9.2 pp |
| 2003 | 86.9% | $10.24 Million | $11.78 Million | $1.54 Million | ▲ +187.6 pp |
| 2002 | -100.7% | $-21.94 Million | $21.80 Million | $43.73 Million | ▼ -192.9 pp |
| 2001 | 92.2% | $22.38 Million | $24.26 Million | $1.88 Million | ▲ +111.0 pp |
| 2000 | -18.7% | $-196.00K | $1.05 Million | $1.24 Million | — |